v3.26.1
SEGMENT REPORTING, GEOGRAPHICAL INFORMATION (Tables)
12 Months Ended
Dec. 31, 2025
Segment Reporting [Abstract]  
SCHEDULE OF BUSINESS SEGMENTS INFORMATION

  

       
   Year December 31, 
   2025   2024 
Revenue:        
Vycor Medical  $1,796,070   $1,515,744 
NovaVision   67,330    73,580 
Revenue  $1,863,400   $1,589,324 
Gross Profit          
Vycor Medical  $1,498,295   $1,355,878 
NovaVision   62,812    66,637 
Gross Profit  $1,561,107   $1,422,515 
           
Operating Income (Loss)          
Vycor Medical  $493,787   $353,052 
NovaVision   (183,878)   (177,917)
Corporate   (276,009)   (184,280)
Operating Income (Loss)   $33,900   $(9,145)

 

   December 31, 2025   December 31, 2024 
Total Assets:          
Vycor Medical  $778,216   $956,061 
NovaVision   51,087    41,139 
Discontinued operations   1,117    917 
Total Assets  $830,420   $998,117 
SUMMARY OF GEOGRAPHIC INFORMATION

  

       
   Year Ended December 31, 
   2025   2024 
Revenue:        
United States  $1,858,494   $1,585,644 
Europe   4,906    3,680 
Revenue  $1,863,400   $1,589,324 
Gross Profit          
United States  $1,556,533   $1,418,970 
Europe   4,574    3,545 
Gross Profit  $1,561,107   $1,422,515 
           
Operating Income (Loss)          
United States  $334,997   $200,111 
Europe   (25,088)   (24,976)
Corporate   (276,009)   (184,280)
Operating Income (Loss)  $33,900   $(9,145)

 

   December 31, 2025   December 31, 2024 
Total Assets:          
United States  $818,237   $991,210 
Europe   11,066    5,990 
Discontinued operations   1,117    917 
Total Assets  $830,420   $998,117